ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Clinical Research Data Management Can Be Easy, With A Little REST

  Uncover how RESTful web services enable different systems to communicate effortlessly, breaking down traditional barriers and allowing for the flexible design of applications that can be accessed across various devices.

• Perspective On The FDA's Final Digital Health Technologies Guidance

  Review the final release of "Digital Health Technologies for Remote Data Acquisition in Clinical Investigations”, where the FDA acknowledges DHT value and the increasing use of them in clinical trials.

• Why Prospective Real-World Studies Hold Promise For Research

  Clinical research has always been a cautious and time-consuming affair. Discover how prospective real-world studies are poised to transform the role of RWE in clinical research.

• Digitizing Multilingual COAs: A Practical Guide

  With pen and paper becoming obsolete in the digital era, shifting to electronic Clinical Outcome Assessments (eCOAs) is becoming more critical than ever. Download the available checklist for a guide through the four main steps required to ensure a successful English build and language migration.

   
• Driving Enrollment Predictability In Clinical Trial Timelines

  Missed enrollment targets cost millions—TA Scan’s benchmarking and simulation tools empower sponsors to forecast with confidence, optimize site strategy, and keep budgets on track.

• EDC Powers End-To-End Data Management In Pharma-Sponsored Trials

  As clinical research moves toward adaptive, decentralized, and data-rich models, EDC remains the backbone that makes innovation operationally feasible.

• Do We Still Need Patients In Tomorrow's Trials?

  Delve into how advanced technologies reshape drug development and patient care, and the crucial balance needed between innovation and ethical responsibility to achieve better trial outcomes.

• IRT? RTSM? What's The Difference?

  What are the components of Randomization and Trial Supply Management (RTSM) and the critical role of RTSM and Interactive Response Technology (IRT) in clinical trials?

• Real-World Evidence - Where Are We Now?

  Notwithstanding ongoing confusion over the concepts of “real-world data” and “real-world evidence” in 2022, more than 5 years after the passage of the 21st Century Cures Act, the FDA continues to evaluate such data and evidence as it considers regulatory decisions.

• Benefits Of Delegating Your Oncology Trials Patient Screening Process

  Explore the integration of Electronic Health Records (EHR) into oncology clinical trials, highlighting both challenges and potential advancements.